title: Movement Disorders: A Brief Guide in Medication Management.
abstract: Movement disorders can be challenging to manage and often use a specific set of medications. Because it is a complex and broad field within neurology, many providers are unfamiliar with the classes of medications. This paper details medications used for specific conditions, explains why these medications are helpful, and shares pearls and pitfalls related to each agent, focusing on parameters such as dose titration, side effect profiles, and specific drug-drug interactions and challenges. We focus on the most commonly encountered movement disorders, including essential tremor, Parkinson's disease, rapid eye movement sleep behavior disorder, and restless leg syndrome.
authors.affiliation: VA Puget Sound, University of Washington Medical Center, 1660 South Columbian Way, Seattle, WA 98108, USA.
authors.forename: Anthony
authors.initials: A
authors.lastname: Julius
authors.affiliation: VA Puget Sound, University of Washington Medical Center, 1660 South Columbian Way, Seattle, WA 98108, USA. Electronic address: katelanlongfellow@catholichealth.net.
authors.forename: Katelan
authors.initials: K
authors.lastname: Longfellow
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D015259:Dopamine Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D020329:Essential Tremor / Q000188:drug therapy; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy; D020187:REM Sleep Behavior Disorder / Q000188:drug therapy; D012148:Restless Legs Syndrome / Q000188:drug therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D000927:Anticonvulsants; D015259:Dopamine Agents; D008996:Monoamine Oxidase Inhibitors
keywords: Essential tremor; Movement disorders; Nonmotor symptoms; Parkinson’s disease; Restless leg syndrome